Glycoprotein IIb/IIIa receptor inhibitor attenuates platelet aggregation induced by thromboxane A2 during in vitro nonpulsatile ventricular assist circulation

Artificial Organs

Volumn 24, Issue 5, 2000, Pages 355-361

  Yomo, Tatsuro ^a   Serna, Dan L ^a   Powell, Ledford L ^a   Wang, Da ^a   Wilson, Samuel E ^a   Ishimaru, Shin ^b   Chen, John C ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^c Division of Cardiothoracic Surgery   (United States)

Author keywords

Glycoprotein IIb IIIa receptor; Platelet aggregation; Platelet secretion; Thromboxane A2; Ventricular assist device

Indexed keywords

COLLAGEN; FIBER OPTIC SENSORS; GLYCOPROTEINS;

ANTITHROMBOTIC; DEGRANULATION; DEVICE CIRCUITS; GLYCOPROTEIN IIB/IIIA RECEPTOR; IN-VITRO; PLATELET AGGREGATION; PLATELET SECRETION; THROMBOXANE A2; VENTRICULAR ASSIST DEVICE; WHOLE BLOOD;

PLATELETS;

ADENOSINE DIPHOSPHATE; COLLAGEN; FIBRINOGEN RECEPTOR ANTAGONIST; RISTOCETIN; THROMBOXANE A2; TIROFIBAN;

ARTICLE; ASSISTED CIRCULATION; DEGRANULATION; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE; THROMBOCYTE RELEASE REACTION;

EID: 0034042033     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2000.06493.x     Document Type: Article

References (30)

1. 1. O'Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994;13:S107-12.
2. 2. Pennington DG, Samuels LD, Williams G, Palmer D, Swartz MT, Codd JE, Merjavy JP, Lagunoff D, Joist JH. Experience with the Pierce-Donachy ventricular assist device in postcardiotomy patients with cardiogenic shock. World J Surg 1985; 9:37-46.
3. 3. Pae WE Jr, Pierce WS. Temporary left ventricular assistance in acute myocardial infarction and cardiogenic shock: Rationale and criteria for utilization. Chest 1981;79:692-5.
4. 4. Jerome SN, Dore M, Paulson JC, Smith CW, Korthuis RJ. P-selectin and ICAM-1-dependent adherence reactions: Role in the genesis of postischemic no-reflow. Am J Physiol 1994; 266:H1316-21.
5. 5. Serna DL, King BO, Jalal R, Tran LM, Huh J, Chen JC. Evidence for selective degradation of platelet GP IIb/IIIa complex after prolonged in vitro ventricular assist. J Invest Med 1998;46(6):279-83.
6. 6. Chen JC, Serna DL, Tran LM, Huh J, Powell LL, King BO, Jalal R, Steward E, Newman RS. Protection of platelet GP IIb/IIIa receptor complex preserves platelet function during in vitro ventricular assisted circulation. ASAIO J 1998;44: M352-5.
7. 7. Vander AJ, Sherman JH, Luciano DS. Human physiology: The mechanism of body function. New York: McGraw-Hill, 1998:451-2.
8. 8. Erez E, Erman A, Snir E, Raanani E, Abramov D, Sulkes J, Boner G, Vidne BA. Thromboxane production in human lung during cardiopulmonary bypass: Beneficial effect of aspirin. Ann Thorac Surgery 1998;65(1):101-6.
9. 2 formation despite administration of a platelet GP IIb/IIIa antagonist in patients undergoing coronary angioplasty. Arterioscler Thromb Vasc Biol 1997;17:3224-9.
10. 2 synthesis. Thromb Haemost 1998;79:1184-90.
11. 2 in reocclusion after thrombolysis. Thromb Haemost 1995;73:4683-8.
12. 12. Brash JL, Scott CF, ten Hove P, Wojciochowski P, Colman RW. Mechanism of transient adsorbtion of fibrinogen from plasma to solid surface: role of the contact and fibinolytic systems. Blood 1988;71:932-9.
13. 13. Musial J, Niewiarowski S, Rucinski B, Stewart GJ, Cook JJ, Williams JA, Edmunds LH Jr. Inhibition of platelet adhesion to surface of extracorporeal circuits by disintegrins. Circulation 1990;82:713-23.
14. 14. Nurden AT. Polymorphisms of human platelets membrane glycoproteins: structure and clinical significance. Thromb Haemost 1995;74:345-513.
15. 15. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptor in cardiovascular medicine. N Engl J Med 1995; 332(23):1553-9.
16. 16. PRISM Study Investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 1998;338:1498-505.
17. 17. RESTORE Investigators. Effects of platelet glycoprotein IIb/ IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation 1997;96:1445-53.
18. 18. EPIC Investigators. Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61.
19. 19. Kereiakes DJ, Lincoff ML, Miller DP, Tscheng JE, Cabot CF, Anderson KM, Weisman HF, Califf RM, Topol EJ for the EPILOG Trial Investigators. Abciximab therapy and unplanned coronary stent deployment. Circulation 1998;97: 857-64.
20. 20. PRISM-PLUS Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tiforiban in unstable angina and no-Q-wave myocardial infarction. N Engl J Med 1998;338:1488-97.
21. 21. Zilla P, Faso R, Groscurth P, Klepetko W, Reichenspurner H, Wolner E. Blood platelets in cardiopulmonary bypass operations. J Thorac Cardiovasc Surg 1989;97:379-88.
22. 22. Schafer AI. Antiplatelet therapy. Am J Med 1996;101: 199-209.
23. 2+ influx into stimulated platelets. Blood 1985;66: 731-4.
24. 24. Yamaguchi A, Tanoue K, Yamazaki I. Secondary signals mediated by GP IIb/IIIa in thrombin-activated platelets. Biochim Biophys Acta 1990;1054:8-13.
25. 25. Lecompte T, Potevin F, Champeix P, Morel MC, Favier R, Hurtaud MF, Schlegel N, Samana M, Kaplan C. Aequorin-detected calcium changes in stimulated thrombasthenic platelet aggregation-dependent calcium movement in response to ADP. Thromb Res 1990;58:561-70.
26. 26. Rybak MEN, Renzulli LA. Effect of calcium channel blockers on platelet GP IIb/IIIa as a calcium channel in liposomes: Comparison with effects on the intact platelet. Thromb Haemost 1992;67:131-6.
27. 27. Carroll RC, Xiao-Fen Wang X, Lanza F, Steiner B, Kouns WC. Blocking platelet aggregation inhibits thromboxane A2 formation by low dose agonists but does not inhibit phosphorylation and activation of cytosolic phospholipase A2. Thromb Res 1997;88:109-25.
28. 28. Detwil TC, Huang EM. The interrelationship of platelet aggregation, secretion, and prostaglandin synthesis. In: Mann KG, Taylor FB Jr, eds. The regulation of coagulation. New York: Elsevier/North-Holland, 1980:377-83.
29. 29. Zucker MB. Observation on the release reaction. In: Mann KG, Taylor FB Jr, eds. The regulation of coagulation. New York: Elsevier/North-Holland, 1980:385-91.
30. 30. Murphy N, Jennings L, Prativo D, Doyle C, Fitzgerald DJ. Functional relevance to LIBS expression in the response to platelet glycoprotein IIb/IIIa antagonists in vivo. Thromb Haemost 1995;73:1314 (Abstract).